Highmount Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$314K Hold
4,805
0.08% 111
2015
Q1
$333K Hold
4,805
0.08% 110
2014
Q4
$332K Hold
4,805
0.08% 110
2014
Q3
$313K Hold
4,805
0.08% 117
2014
Q2
$328K Buy
4,805
+30
+0.6% +$2.01K 0.08% 121
2014
Q1
$310K Buy
4,775
+25
+0.5% +$1.57K 0.07% 121
2013
Q4
$310K Sell
4,750
-1,600
-25% -$102K 0.07% 119
2013
Q3
$377K Sell
6,350
-26
-0.4% -$1.54K 0.09% 99
2013
Q2
$365K Buy
+6,376
New +$378K 0.1% 103

Other funds holding CL

Highmount Capital's CL Position: Q2 2015 in Review

Highmount Capital held its Colgate-Palmolive (CL) position steady in Q2 2015 at 4,805 shares worth $314K. The position accounts for 0.08% of the portfolio, ranked #111.

Highmount Capital first reported a position in CL in Q2 2013 and has held it in 9 quarters since. The position peaked at $377K in Q3 2013. 1,234 funds tracked by Wall St. Rank hold CL as of Q2 2015.

  • Highmount Capital held 4,805 shares of Colgate-Palmolive worth $314K as of Q2 2015.
  • Highmount Capital left its Colgate-Palmolive share count unchanged in Q2 2015.
  • Colgate-Palmolive made up 0.08% of Highmount Capital's portfolio in Q2 2015, its #111 holding.
  • Highmount Capital first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 9 quarters since.
  • Highmount Capital's Colgate-Palmolive position peaked at $377K in Q3 2013.
  • 1,234 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2015.

Based on Highmount Capital's 13F filing for Q2 2015, filed 14 Aug 2015.